BTMD (Biote Corporation) חוב להון עצמי

biote Corp. (BTMD) maintains a conservative ESG policy, focusing on waste disposal. The business relies on innovations in healthy aging and training medical professionals to work with pellets. This daily price action on the GURU.Markets platform clearly visualizes a coefficient of 0.00, confirming the sector's resilience to crises despite raw material logistics risks and challenges with foreign drug certification.

Investors seek asset stability by analyzing the structure of its liabilities. Stable cash flow from hormone replacement therapy provides biote Corp. with financial autonomy. This total debt-to-equity ratio measures the proportion of borrowed funds relative to the company's own resources. A high ratio signals a risk of credit dependence, whereas a low ratio confirms the business's self-sufficiency. The current trend of this indicator confirms the reliability of the fundamental model of BTMD.